Uveitis Overview

The MUST study has significantly enhanced the evidence base for managing ocular inflammatory diseases, particularly those related to eye diseases. This vital research received primary support through NIH grants. Dr. Douglas A. Jabs chairs the MUST study, while Dr. John Kempen serves as Vice-Chair and Protocol Chair for the MUST Follow-up Study. Additionally, Dr. Janet Holbrook is the Coordinating Center Director, Dr. Michael Altaweel functions as the Reading Center Director, and Dr. Elizabeth Sugar is the Principal Statistician.

The SITE study has significantly enhanced the evidence base for managing ocular inflammatory diseases, particularly in the context of eye diseases. This important research has been primarily supported through NIH grants. The SITE study is chaired by Dr. John H. Kempen, who plays a pivotal role in advancing our understanding of inflammation in these conditions.